Abstract:Importance The ketogenic diet (KD) has been used successfully to treat children with drug-resistant epilepsy. Data assessing the efficacy of the modified Atkins diet (MAD) and low glycemic index therapy (LGIT) diet compared with the KD are scarce. Objective To determine whether the MAD and LGIT diet are noninferior to the KD among children with drug-resistant epilepsy. Design, Setting, and Participants One hundred seventy children aged between 1 and 15 years who had 4 or more seizures per month, had not responded to 2 or more antiseizure drugs, and had not been treated previously with the KD, MAD, or LGIT diet were enrolled between April 1, 2016, and August 20, 2017, at a tertiary care referral center in India. Exposures Children were randomly assigned to receive the KD, MAD, or LGIT diet as additions to ongoing therapy with antiseizure drugs. Main Outcomes and Measures Primary outcome was percentage change in seizure frequency after 24 weeks of dietary therapy in the MAD cohort compared with the KD cohort and in the LGIT diet cohort compared with the KD cohort. The trial was powered to assess noninferiority of the MAD and LGIT diet compared with the KD with a predefined, noninferiority margin of -15 percentage points. Intention-to-treat analysis was used. Results One hundred fifty-eight children completed the trial: KD (n = 52), MAD (n = 52), and LGIT diet (n = 54). Intention-to-treat analysis showed that, after 24 weeks of intervention, the median (interquartile range [IQR]) change in seizure frequency (KD: -66%; IQR, -85% to -38%; MAD: -45%; IQR, -91% to -7%; and LGIT diet: -54%; IQR, -92% to -19%) was similar among the 3 arms (P = .39). The median difference, per intention-to-treat analysis, in seizure reduction between the KD and MAD arms was -21 percentage points (95% CI, -29 to -3 percentage points) and between the KD and LGIT arms was -12 percentage points (95% CI, -21 to 7 percentage points), with both breaching the noninferiority margin of -15 percentage points. Treatment-related adverse events were similar between the KD (31 of 55 [56.4%]) and MAD (33 of 58 [56.9%]) arms but were significantly less in the LGIT diet arm (19 of 57 [33.3%]). Conclusions and Relevance Neither the MAD nor the LGIT diet met the noninferiority criteria. However, the results of this study for the LGIT diet showed a balance between seizure reduction and relatively fewer adverse events compared with the KD and MAD. These potential benefits suggest that the risk-benefit decision with regard to the 3 diet interventions needs to be individualized. Trial Registration ClinicalTrials.gov Identifier: NCT02708030.

Ketogenic diet in patients with Lennox-Gastaut syndrome

Therapeutic Effects of the Ketogenic Diet in Children with Lennox-Gastaut Syndrome

Ketogenic Diet in patients with refractory epilepsy

Ketogenic diet in patients with Dravet syndrome

Ketogenic diet in patients with epileptic encephalopathy with electrical status epilepticus during slow sleep

Ketogenic Diets in the Treatment of Epilepsy

The ketogenic diet in patients with myoclonic status in non-progressive encephalopathy

Prospective Study on Ketogenic Diet on Refractory Epilepsy in Children

A Prospective Study on Changes in Nutritional Status and Growth Following Two Years of Ketogenic Diet (KD) Therapy in Children with Refractory Epilepsy

Efficacy and safety of ketogenic diet for treatment of pediatric convulsive refractory status epilepticus

Ketogenic diet use in children with intractable epilepsy secondary to malformations of cortical development: A two- centre experience

Safety and Effectiveness of the Prolonged Treatment of Children with a Ketogenic Diet

Prospective study of the efficacy of a ketogenic diet in 20 patients with Dravet syndrome

Effectiveness of the ketogenic diet used to treat resistant childhood epilepsy in Scandinavia

Efficacy and safety of a ketogenic diet in children with drug-resistant epilepsy

Use of the ketogenic diet to manage refractory epilepsy in CDKL5 disorder: Experience of >100 patients

The Efficacy of Ketogenic Diet in 60 Chinese Patients with Dravet Syndrome

Efficacy of Ketogenic Diet, Modified Atkins Diet, and Low Glycemic Index Therapy Diet Among Children With Drug-Resistant Epilepsy: A Randomized Clinical Trial.

Short-term effectiveness and side effects of ketogenic diet for drug-resistant epilepsy in children with genetic epilepsy syndromes

[Ketogenic diet as antiepileptic therapy: a description of the clinical experience and the multidisciplinary approach at the metabolic-neurogenetic clinic at the Wolfson Medical Center]

The MCT-ketogenic diet as a treatment option in refractory childhood epilepsy: A prospective study with 2-year follow-up